Year |
Citation |
Score |
2011 |
Gray P, Kirby J, Smith MT, Cabot PJ, Williams B, Doecke J, Cramond T. Pregabalin in severe burn injury pain: a double-blind, randomised placebo-controlled trial. Pain. 152: 1279-88. PMID 21398038 DOI: 10.1016/J.Pain.2011.01.055 |
0.525 |
|
2005 |
McCahon S, Strong J, Sharry R, Cramond T. Self-report and pain behavior among patients with chronic pain. The Clinical Journal of Pain. 21: 223-31. PMID 15818074 DOI: 10.1097/00002508-200505000-00005 |
0.339 |
|
2004 |
Cramond T. Book Review: Opioids and Pain Relief: A Historical Perspective Anaesthesia and Intensive Care. 32: 442-442. DOI: 10.1177/0310057X0403200327 |
0.322 |
|
2001 |
Nissen LM, Tett SE, Cramond T, Williams B, Smith MT. Opioid analgesic prescribing and use - an audit of analgesic prescribing by general practitioners and The Multidisciplinary Pain Centre at Royal Brisbane Hospital. British Journal of Clinical Pharmacology. 52: 693-8. PMID 11736881 DOI: 10.1046/J.0306-5251.2001.01502.X |
0.583 |
|
1999 |
Keates HL, Cramond T, Smith MT. Intraarticular and periarticular opioid binding in inflamed tissue in experimental canine arthritis. Anesthesia and Analgesia. 89: 409-15. PMID 10439757 DOI: 10.1097/00000539-199908000-00030 |
0.499 |
|
1999 |
Smith MT, Wright AW, Williams BE, Stuart G, Cramond T. Cerebrospinal fluid and plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in patients before and after initiation of intracerebroventricular morphine for cancer pain management. Anesthesia and Analgesia. 88: 109-16. PMID 9895076 DOI: 10.1097/00000539-199901000-00021 |
0.587 |
|
1998 |
Wright AW, Lawrence JA, Iu M, Cramond T, Smith MT. Solid-phase extraction method with high-performance liquid chromatography and electrochemical detection for the quantitative analysis of oxycodone in human plasma. Journal of Chromatography. B, Biomedical Sciences and Applications. 712: 169-75. PMID 9698239 DOI: 10.1016/S0378-4347(98)00146-7 |
0.464 |
|
1997 |
Cabot PJ, Cramond T, Smith MT. Morphine has a dual concentration-dependent effect on K(+)-evoked substance P release from rat peripheral airways. Pulmonary Pharmacology & Therapeutics. 10: 215-21. PMID 9695145 DOI: 10.1006/Pupt.1997.0094 |
0.517 |
|
1996 |
Cabot PJ, Cramond T, Smith MT. Quantitative autoradiography of peripheral opioid binding sites in rat lung. European Journal of Pharmacology. 310: 47-53. PMID 8880066 DOI: 10.1016/0014-2999(96)00363-9 |
0.527 |
|
1995 |
Leow KP, Cramond T, Smith MT. Pharmacokinetics and pharmacodynamics of oxycodone when given intravenously and rectally to adult patients with cancer pain. Anesthesia and Analgesia. 80: 296-302. PMID 7818116 DOI: 10.1097/00000539-199502000-00016 |
0.547 |
|
1994 |
Bartlett SE, Cramond T, Smith MT. The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. Life Sciences. 54: 687-94. PMID 8107513 DOI: 10.1016/0024-3205(94)00552-4 |
0.607 |
|
1994 |
Wright AW, Watt JA, Kennedy M, Cramond T, Smith MT. Quantitation of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in plasma and cerebrospinal fluid using solid-phase extraction and high-performance liquid chromatography with electrochemical detection. Therapeutic Drug Monitoring. 16: 200-8. PMID 8009570 DOI: 10.1097/00007691-199404000-00016 |
0.575 |
|
1994 |
Cabot PJ, Dodd PR, Cramond T, Smith MT. Characterization of non-conventional opioid binding sites in rat and human lung. European Journal of Pharmacology. 268: 247-55. PMID 7957646 DOI: 10.1016/0922-4106(94)90195-3 |
0.511 |
|
1994 |
Smith M, Cramond T. Comments on Goucke et al., PAIN, 56 (1994) 145-149. Pain. 59: 155-6. PMID 7854800 DOI: 10.1016/0304-3959(94)90065-5 |
0.466 |
|
1994 |
Strong J, Ashton R, Chant D, Cramond T. An Investigation of the Dimensions of Chronic Low Back Pain: The Patients' Perspectives British Journal of Occupational Therapy. 57: 204-208. DOI: 10.1177/030802269405700602 |
0.331 |
|
1993 |
Stuart G, Cramond T. Role of percutaneous cervical cordotomy for pain of malignant origin. The Medical Journal of Australia. 158: 667-70. PMID 8487684 DOI: 10.5694/J.1326-5377.1993.Tb121912.X |
0.319 |
|
1993 |
Leow KP, Wright AW, Cramond T, Smith MT. Determination of the serum protein binding of oxycodone and morphine using ultrafiltration. Therapeutic Drug Monitoring. 15: 440-7. PMID 8249052 DOI: 10.1097/00007691-199310000-00014 |
0.501 |
|
1993 |
Cramond T, Stuart G. Intraventricular morphine for intractable pain of advanced cancer. Journal of Pain and Symptom Management. 8: 465-73. PMID 7963773 DOI: 10.1097/00132586-199410000-00033 |
0.431 |
|
1992 |
Leow KP, Smith MT, Watt JA, Williams BE, Cramond T. Comparative oxycodone pharmacokinetics in humans after intravenous, oral, and rectal administration. Therapeutic Drug Monitoring. 14: 479-84. PMID 1485370 DOI: 10.1097/00007691-199212000-00008 |
0.504 |
|
1992 |
Cramond T, Smith MT, Watt JA. Comments on Gong et al., PAIN, 48 (1992) 249-255. Pain. 51: 124-5. PMID 1454398 DOI: 10.1016/0304-3959(92)90022-4 |
0.466 |
|
1992 |
Leow KP, Smith MT, Williams B, Cramond T. Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer. Clinical Pharmacology and Therapeutics. 52: 487-95. PMID 1424423 DOI: 10.1038/Clpt.1992.176 |
0.542 |
|
1991 |
Smith MT, Watt JA, Mapp GP, Cramond T. Quantitation of oxycodone in human plasma using high-performance liquid chromatography with electrochemical detection. Therapeutic Drug Monitoring. 13: 126-30. PMID 2053119 DOI: 10.1097/00007691-199103000-00007 |
0.501 |
|
1990 |
Smith MT, Watt JA, Cramond T. Morphine-3-glucuronide--a potent antagonist of morphine analgesia. Life Sciences. 47: 579-85. PMID 2402182 DOI: 10.1016/0024-3205(90)90619-3 |
0.576 |
|
1990 |
Strong J, Ashton R, Cramond T, Chant D. Pain intensity, attitude and function in back pain patients Australian Occupational Therapy Journal. 37: 179-183. DOI: 10.1016/0304-3959(90)93108-A |
0.34 |
|
1990 |
Stuart G, Cramond T, Jamieson KG. Percutaneous cordotomy for malignant pain Pain. 41: S414. DOI: 10.1016/0304-3959(90)92943-K |
0.333 |
|
1990 |
Smith MT, Cramond T. Morphine-3-Glucuronide — A potent antagonist of morphine analgesia Pain. 41: S186. DOI: 10.1016/0304-3959(90)92509-O |
0.54 |
|
1990 |
Cramond T, Smith M, Watt J, Kute S, Mapp G. High Performance Liquid Chromatography (HPLC) determination of oxycodone in human plasma after oral, rectal and intravenous routes Pain. 41: S176. DOI: 10.1016/0304-3959(90)92488-C |
0.462 |
|
1989 |
Strong J, Cramond T, Maas F. The effectiveness of relaxation techniques with patients who have chronic low back pain Occupational Therapy Journal of Research. 9: 184-192. DOI: 10.1177/153944928900900305 |
0.33 |
|
Show low-probability matches. |